SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as its strong Q4 earnings, profitability, and new share buyback authorization have ironically led to a significant stock decline, sparking widespread frustration among investors. The community is fiercely debating whether ongoing stock-based compensation and dilution are overshadowing the company's growth in subscriptions and long-term potential in AI/AR smartglasses.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings Inc. is trending after the abrupt departures of its CFO and General Counsel amid an ongoing accounting review, an SEC investigation, and disclosures of material weaknesses in internal controls and a lowered fiscal outlook. The community is sharply divided, with many voicing deep concerns about potential fraud and a continued decline, while others are aggressively buying the significant dip, anticipating an oversold rebound.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the FDA's swift action against compounded GLP-1s from Hims & Hers validates legitimate drug development, amplifying speculation that Viking's "best-in-class" VK2735 is a critical acquisition for companies like Novo Nordisk, which face intense competition from Eli Lilly in the booming obesity market.

Investment Managers Series Trust II - Tradr 2X Long CRML Daily ETF

Tradr 2X Long CRML Daily ETF

Tradr's recently launched 2X leveraged ETF, $CRMX, tracking Critical Metals ($CRML) and its rare earth projects, is actively discussed as traders debate its actual leverage performance and monitor for a potential breakout from quiet accumulation on increased volume. Many are closely watching its tight consolidation and small float dynamics for an upward move.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is trending following its recent earnings report, which showed a revenue miss attributed to contract transitions and a government shutdown, despite an EPS beat and a growing backlog. The community is actively debating whether the post-earnings stock dip is an over-reaction, with many long-term investors highlighting the company's crucial role in nuclear energy, space systems, and defense contracts as a strong foundation for future growth.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is trending for its notable resilience and positive price action in a challenging market, driven by a dedicated community actively accumulating and promoting its narrative as the "third frog" and literal representation of Pepe by creator Matt Furie. Despite some labeling it a scam, proponents are confident in its organic growth and potential as a prime frog meta beta play.

Dynatrace, Inc. engages in the advancing observability for today’s digital businesses, helping to transform the complexity of modern digital ecosystems into powerful business assets. By leveraging AI-powered insights, Dynatrace enables organizations to analyze, automate, and innovate faster to drive their business forward. The company was founded by Bernd Greifeneder in 2005 and is headquartered in Boston, MA.

Dynatrace Inc

Dynatrace is trending following its strong Q3 fiscal year 2026 earnings report, which surpassed expectations across key metrics and included the authorization of a $1 billion share repurchase program. This positive financial performance and commitment to shareholder returns are fueling optimistic discussions among the community, despite some recent analyst target adjustments.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending following its strategic pivot to an AI-enabled fintech platform, CapForce, with the community actively discussing an anticipated NASDAQ relisting and the potential for explosive price movements given its extremely low float. Recent compliance filings and strategic acquisitions are fueling optimism for its new direction.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund (UUP) is trending as the US dollar faces pressure from widespread expectations of future Fed rate cuts and a broader "risk-on" market sentiment favoring equities and commodities. The community is discussing a potential dollar breakdown, with some linking weakness to de-dollarization concerns and a surge in precious metals like gold and silver.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum (LITE) is trending as a critical optical component supplier for the booming AI data center infrastructure, fueled by its collaboration on Nvidia's power-efficient silicon photonics and a recent earnings beat with strong guidance. The community is actively discussing its significant growth potential as an AI networking backbone versus concerns about its rapid valuation surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Henry Schein, Inc. $HSIC Shares Sold by Nuance Investments LLC

Nuance Investments LLC cut its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 61.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange...

Henry Schein (NASDAQ:HSIC) Hits New 1-Year High - Here's What Happened

Henry Schein (NASDAQ:HSIC) Sets New 12-Month High - Time to Buy...

Henry Schein, Inc. $HSIC Shares Bought by M.D. Sass LLC

M.D. Sass LLC raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 21.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the...

A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program

The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming childrens lives...

Dilation Capital Management LP Invests $5.11 Million in Henry Schein, Inc. $HSIC

Dilation Capital Management LP bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities...

Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have received an average rating of "Hold" from the fourteen brokerages that are currently covering the stock, Marketbeat reports. One...

Henry Schein (NASDAQ:HSIC) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?

Henry Schein (NASDAQ:HSIC) Share Price Crosses Above 200-Day Moving Average - Time to Sell...

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Henry Schein Names Frederick M. Lowery as Chief Executive Officer

Henry Schein, Inc. (Nasdaq: HSIC), the worlds largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its...

HSIC or SAUHY: Which Is the Better Value Stock Right Now?

HSIC vs. SAUHY: Which Stock Is the Better Value Option?

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

HSIC
Henry Schein Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HSIC News

HSICHenry Schein Inc.